A new way of defining clinical endpoints with Sébastien Coppe

Join host Sylvain Berthelot and Sébastien Coppe, CEO and co-founder of One2Treat, to explore a patient-focused approach to redefining clinical endpoints. Drawing from his background in optimizing clinical supply chains and his passion for involving patients more deeply in trial design, Sébastien shares how One2Treat is using technology to bring the patient’s voice into the earliest stages of clinical development.

The discussion touches on the limitations of traditional endpoints, the value of co-designing studies with patients, and the promise of tools that capture lived experiences to define outcomes that truly matter. Sébastien emphasizes the need to rethink how we measure success in trials, through real-world impact and patient relevance.

Tune in to discover how new statistical approaches are enabling a more meaningful way to define what good looks like in clinical research.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

From our operations leaders David Im & Marci Mogg

When speaking with David and Marci, we realize how naturally their perspectives complement each other, from their user focus to how they influence product design.

The must-haves for today’s eClinical vendors

What sets CRScube and Mednet apart is their ability to support global studies with local understanding, regional expertise, and a broad, complementary technology portfolio.

cubeCDMS is now rated #1 EDC solution by users on G2

In clinical research, where data integrity, compliance, speed, and usability all matter, having an EDC system that genuinely works makes a huge difference.